Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data.


Journal

Annals of epidemiology
ISSN: 1873-2585
Titre abrégé: Ann Epidemiol
Pays: United States
ID NLM: 9100013

Informations de publication

Date de publication:
05 2019
Historique:
received: 19 06 2018
revised: 24 01 2019
accepted: 31 01 2019
pubmed: 22 4 2019
medline: 6 2 2020
entrez: 22 4 2019
Statut: ppublish

Résumé

Use of electronic health records (EHRs) in health research may lead to the false assumption of complete event ascertainment. We estimated "observation windows" (OWs), defined as periods within which the assumption of complete ascertainment of events is more likely to hold, as a quality control approach to reducing the likelihood of this false assumption. We demonstrated the impact of OWs on estimating the rates of type II diabetes mellitus (diabetes) from HIV clinical cohorts. Data contributed by 16 HIV clinical cohorts to the NA-ACCORD were used to identify and evaluate OWs for an operationalized definition of diabetes occurrence as a case study. Procedures included (1) gathering cohort-level data; (2) visualizing and summarizing gaps in observations; (3) systematically establishing start and stop dates during which the assumption of complete ascertainment of diabetes events was reasonable; and (4) visualizing the diabetes OWs relative to the cohort open and close dates to identify immortal person-time. We estimated diabetes occurrence event rates and 95% confidence intervals in the most recent decade that data were available (January 1, 2007, to December 31, 2016). The number of diabetes events decreased by 17% with the use of the diabetes OWs; immortal person-time was removed decreasing total person-years by 23%. Consequently, the diabetes rate increased from 1.23 (95% confidence interval [1.20, 1.25]) per 100 person-years to 1.32 [1.29, 1.35] per 100 person-years with the use of diabetes OWs. As the use of EHR-curated data for event-driven health research continues to expand, OWs have utility as a quality control approach to complete event ascertainment, helping to improve accuracy of estimates by removing immortal person-time when ascertainment is incomplete.

Identifiants

pubmed: 31005552
pii: S1047-2797(18)30540-4
doi: 10.1016/j.annepidem.2019.01.015
pmc: PMC6502687
mid: NIHMS1523084
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-63

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI031834
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI038855
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007587
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI037613
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068634
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020790
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA012568
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000004
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA016893
Pays : United States
Organisme : NCI NIH HHS
ID : N01 CP001004
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027767
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035042
Pays : United States
Organisme : NIAID NIH HHS
ID : F31 AI124794
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062246
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069434
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI037984
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103397
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA011602
Pays : United States
Organisme : NEI NIH HHS
ID : K23 EY013707
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA165937
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035004
Pays : United States
Organisme : NIMHD NIH HHS
ID : G12 MD007583
Pays : United States
Organisme : NIDA NIH HHS
ID : K24 DA000432
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA036935
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024131
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034989
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035041
Pays : United States
Organisme : NIAID NIH HHS
ID : R24 AI067039
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI035043
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069432
Pays : United States
Organisme : NCI NIH HHS
ID : N02CP55504
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI038858
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY008057
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI068636
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034994
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR000052
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000454
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY008052
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI110527
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI093197
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069918
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI118591
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI065298
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103401
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA013566
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002317
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000083
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR000421
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035040
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI131895
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103390
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034993
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103408
Pays : United States
Organisme : NIDA NIH HHS
ID : F31 DA037788
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035039
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG053100
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY008067
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI036219
Pays : United States
Organisme : Intramural NIH HHS
ID : Z01 CP010176
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146194
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA020794
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI068634
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD032632
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI042590
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Ann Intern Med. 2010 Oct 19;153(8):536-9
pubmed: 20733178
Arthritis Care Res (Hoboken). 2010 Aug;62(8):1120-7
pubmed: 20235204
Int J Epidemiol. 2018 Apr 1;47(2):654-668
pubmed: 29438495
Sci Transl Med. 2011 Apr 20;3(79):79re1
pubmed: 21508311
Am J Manag Care. 2010 Dec;16(12 Suppl HIT):SP24-8
pubmed: 21314216
J Clin Epidemiol. 2005 Apr;58(4):323-37
pubmed: 15862718
Annu Rev Public Health. 1987;8:51-74
pubmed: 3555530
IEEE J Biomed Health Inform. 2015 Jul;19(4):1193-208
pubmed: 26173222
Med Care Res Rev. 2009 Dec;66(6):611-38
pubmed: 19279318
Med Care. 2013 Aug;51(8 Suppl 3):S30-7
pubmed: 23774517
Int J Epidemiol. 2007 Apr;36(2):294-301
pubmed: 17213214
J Clin Epidemiol. 1994 Mar;47(3):249-60
pubmed: 8138835
Clin Infect Dis. 2017 Feb 15;64(4):459-467
pubmed: 28172581
Med Care. 2002 Aug;40(8):675-85
pubmed: 12187181
Expert Rev Pharmacoecon Outcomes Res. 2013 Apr;13(2):191-200
pubmed: 23570430
Int J Risk Saf Med. 1997;10(1):1-22
pubmed: 23511270
Int J Epidemiol. 1996 Apr;25(2):435-42
pubmed: 9119571
J Am Med Inform Assoc. 2003 Jan-Feb;10(1):1-10
pubmed: 12509352

Auteurs

Keri N Althoff (KN)

Johns Hopkins University, Baltimore, MD. Electronic address: kalthoff@jhu.edu.

Cherise Wong (C)

Johns Hopkins University, Baltimore, MD.

Brenna Hogan (B)

Johns Hopkins University, Baltimore, MD.

Fidel Desir (F)

Johns Hopkins University, Baltimore, MD.

Bin You (B)

Johns Hopkins University, Baltimore, MD.

Elizabeth Humes (E)

Johns Hopkins University, Baltimore, MD.

Jinbing Zhang (J)

Johns Hopkins University, Baltimore, MD.

Yuezhou Jing (Y)

Johns Hopkins University, Baltimore, MD.

Sharada Modur (S)

Johns Hopkins University, Baltimore, MD.

Jennifer S Lee (JS)

Johns Hopkins University, Baltimore, MD.

Aimee Freeman (A)

Johns Hopkins University, Baltimore, MD.

Mari Kitahata (M)

University of Washington, Seattle.

Stephen Van Rompaey (S)

University of Washington, Seattle.

W Christopher Mathews (WC)

University of California San Diego, San Diego.

Michael A Horberg (MA)

Kaiser Permanente Mid-Atlantic Permanente Research Institute, Rockville, MD.

Michael J Silverberg (MJ)

Kaiser Permanente Northern California, Oakland, CA.

Angel M Mayor (AM)

Universidad Central del Caribe, Bayamon, Puerto Rico.

Kate Salters (K)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.

Richard D Moore (RD)

Johns Hopkins University, Baltimore, MD.

Stephen J Gange (SJ)

Johns Hopkins University, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH